-Multi-year agreement with Intuitive Surgical-Significant commercial opportunity-Current year off to strong startMinimally invasive electrosurgical devices company Creo Medical (CREO:AIM) provided a positive update on results to December 2021 and announced a collaboration with the world's leading surgical robotics company.Creo Medical has signed a multi-year agreement with US listed Intuitive...

Creo Medical (CREO:AIM) is aiming to bring forward its US commercial launch plans after its medical device Speedboat RS2 was approved by the US Food and Drug Administration in only 49 days.The approval for the disposable device for the treatment of colorectal cancer is six months ahead of schedule and could bode well for future product launches.